Yüklüyor......
1554. Nebulized Liposomal Amphotericin B for Treatment of Murine Pulmonary Mucormycosis
BACKGROUND: Pulmonary mucormycosis, a life-threatening infection of immunocompromised individuals, can have a 95% mortality rate, even with treatment. Intravenous (IV) liposomal amphotericin B (AmBisomeâ, AmBi) is used to treat the infection, but rapid growth of the pathogen can limit the drug’s eff...
Kaydedildi:
| Yayımlandı: | Open Forum Infect Dis |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6810164/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1418 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|